5AM Opportunities II (GP), LLC

SEC CIK: 0001873515

SEC filings (opens in a new tab)

No open-market purchases or sales filed in the past year.

Current role at each company

LTGO Latigo Biotherapeutics, Inc.10% Owneras of Aug 12, 2026
CAMP Camp4 Therapeutics Corp10% Owneras of Aug 5, 2026
ARTV Artiva Biotherapeutics, Inc.10% Owneras of Jul 24, 2024
CINC CinCor Pharma, Inc.10% Owneras of Feb 28, 2023

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: –; 0 filings
Net: –; Bought minus sold
Companies: 0; With open-market trades

Trades

Every Form 4 that lists 5AM Opportunities II (GP), LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

CAMP Camp4 Therapeutics Corp

10% Owner3 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Aug 5, 2026 (view filing)5:39 PM ET	Aug 3	2 days	Parmar Kush and 6 others10% Owner	PPurchase	+3.18M	$1.53	+$4.86M	–3.18M after	Derivative
Sep 15, 2025 (view filing)8:12 PM ET	Sep 11	4 days	Parmar Kush and 6 others10% Owner	PPurchase	+2.94M	$1.53	+$4.50M	New position2.94M after
Oct 15, 2024 (view filing)5:56 PM ET	Oct 15	Same day	Parmar Kush and 4 others10% Owner	PPurchase	+909.1K	$11.00	+$10.0M	+53.0%2.63M after	Duplicate filing

ARTV Artiva Biotherapeutics, Inc.

10% Owner1 trade

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Jul 24, 2024 (view filing)4:15 PM ET	Jul 22	2 days	Schwab Andrew J. and 5 others10% Owner	PPurchase	+833.3K	$12.00	+$10.0M	+239.0%1.18M after

CINC CinCor Pharma, Inc.